News

Scientific American12h
Why mRNA Vaccines Are So Revolutionary—And What's at Stake If We Lose Them
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...
Axios on MSN13h
What to know about mRNA vaccines as Trump admin pulls funding
The Trump administration is decreasing funding for the development of mRNA (messenger RNA) vaccines, which were crucial in ...
STAT17h
Pharmalittle: We’re reading about BARDA terminating mRNA grants, Trump’s pharma tariff threats, and more
RFK Jr. announced that the U.S. government’s emergency preparedness agency will no longer fund work on mRNA vaccines ...
mRNA Vaccine Tech Could Transform Medicine and Cure Diseases. RFK, Jr. Just Pulled Its Funding
The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects dedicated to designing messenger RNA (mRNA) vaccines for pandemic preparedness.
Barchart on MSN1d
Moderna Stock: Is Wall Street Bullish or Bearish?
With a market cap of $10.7 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of ...
Fred Hutchinson Cancer Center1d
Conducting RNA reconnaissance
Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...
Mystery of how cells prevent premature protein release solved
All living organisms' genetic information is stored in DNA, which is transcribed into RNA, which is translated into proteins ...